Alexandra Lahav is an expert in complex litigation, class actions, and mass torts. She is the author of a prize winning book, In Praise of Litigation (Oxford University Press 2017) and popular casebook on civil procedure.
Areas of Expertise (6)
Drug and Device Litigation
Harvard Law School: J.D. 1998
Brown University: B.A., History 1993
Branstetter New Voices in Civil Justice Workshop (professional)
Awarded by the Vanderbilt Law School.
Zacharias Prize in Professional Responsibility (professional)
Awarded by the Association of American Law Schools
Media Appearances (15)
Major drugstore chains sue doctors in sprawling federal opioid case
Washington Post print
Alexandra Lahav, a professor at the University of Connecticut School of Law who also follows the case, said the companies may be signaling to Polster that if pharmacists are going to be held responsible for their dispensing activity, they will want to examine the prescribing habits of doctors across the two counties — a seemingly huge task.
“This is an illustration of how complex and maybe impossible it may be to prove the underlying claim that Cuyahoga County is trying to prove against these drugstores,” she said. “Are we going to question every time we dispensed a drug over a 20-year period?”
Cuyahoga And Summit Zero In On Next Opioid Defendants: Pharmacies
WKSU - NPR radio
Meanwhile, it’s still unclear whether states, counties and drug companies can agree to a universal settlement that would lay to rest all of the lawsuits over the opioid crisis.
The Sixth U.S. Circuit Court of Appeals has said it will review a proposal to include all cities and counties in the country in a special class that could vote on potential settlements. State attorneys general have opposed the novel plan.
“It’s never been tried before, and it would have given them some pretty big leverage to settle with the defendants,” University of Connecticut law professor Alexandra Lahav said, “because they could promise the defendants that everyone was included.”
High-profile trial over who should pay for the opioid crisis begins
Washington Post print
Described as the most complex litigation ever, the trial will begin to sort out the welter of accusations over the crisis. While six drug companies are defendants in the case, jurors also may hear blame cast widely on doctors, government agencies and perhaps even drug users themselves. The jury’s response will help decide who should bear the cost of one of this century’s worst public health crises.
“What’s pushing them to trial is the attempt to reach a settlement in a vacuum and the difficulty of doing that,” said Alexandra Lahav, a professor at the University of Connecticut School of Law who studies mass tort cases like this one.
Your Guide To The Massive (And Massively Complex) Opioid Litigation
"The usual class action — the way it works is you have a class representative and they decide whether it's a good settlement or not. Here we're letting people vote. We have a much bigger input — that's the novel thing here," says Alexandra Lahav, a University of Connecticut law professor.
"This is totally uncharted territory," she adds. "There's no model for any of it."
Johnson & Johnson ordered to pay $572 million for its role in Oklahoma’s opioid crisis
Washington Post print
Alexandra Lahav, a professor at the University of Connecticut School of Law, said it’s too early to predict the impact of Balkman’s decision on future cases.
“I think it’s important that people remember that this is just Oklahoma law, and it’s a lower court judge,” she said. “It hasn’t been vetted on appeal yet.”
Bayer could benefit from home advantage in St. Louis Roundup cancer trial: experts
By suing in the county where Bayer’s crop science business is headquartered, plaintiffs can also take advantage of procedural rules allowing them to compel live testimony from executives who work locally. In the California trials, jurors only saw video depositions of Monsanto executives.
But Alexandra Lahav, a law professor at the University of Connecticut, said Bayer could simply be using new experts that the company thinks would have a better rapport with the jury and “not necessarily because the experts are local.”
Eyes turn to courts for recompense
Washington Post print
“Johnson & Johnson has been, in a bunch of cases, not afraid to litigate,” said Alexandra Lahav, professor at the University of Connecticut School of Law. “This is not the only mass tort they’re dealing with, and they have been pretty aggressive in their litigation strategy,” she said, citing the company’s defense against lawsuits from women who claimed that asbestos in the company’s talc products gave them cancer.
J&J Called a 'Kingpin' in Opioid Case That Could Be a Test for 1,600 More Lawsuits
“Public nuisance claims are somewhat adventuresome,” notes Alexandra Lahav of the University of Connecticut School of Law. “It’s not an area that has been well litigated. So whenever you have a public nuisance claim, you are always striking new ground. That’s more opportunity, but it also means it’s hard to predict for us looking from the outside what this judge is going to do.”
Purdue Pharma agrees to $270 million settlement in Oklahoma opioid case
Avoiding the trial with a settlement relieves immediate pressure on Purdue to seek bankruptcy protection, said Alexandra Lahav, a professor at the University of Connecticut School of Law.
While the company has not ruled out a bankruptcy filing, it now plans to focus on attempting a settlement with other state and local governments pursuing similar cases, a person familiar with Purdue’s deliberations said.
Bayer Levels Sights On Weedkiller Verdict
Wall Street Journal print
Bayer AG is stepping up the legal defense of its flagship weedkiller, after a recent verdict in a case alleging the chemical causes cancer sent shares down sharply and raised the prospect of costly plaintiff payouts.
"For Bayer, the most important thing is to have a judge say the [plaintiff's] science doesn't hold up," Alexandra Lahav, a law professor at the University of Connecticut, said in reference to the Roundup case.
Facing Wave of Opioid Lawsuits, Drug Companies Sprinkle Charity on Hard-Hit Areas
The drug industry is dishing out millions in grants and donations to organizations in cities, counties and states that have sued the companies over the deadly U.S. opioid epidemic.
Alexandra Lahav, a University of Connecticut School of Law professor, said the contributions could be a tactic in settlement talks or discussions with regulators, and while the donations wouldn’t be applied dollar-for-dollar in a settlement agreement, they show goodwill on the part of the company.
Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
Bayer AG unit Monsanto faces long odds on an appeal blaming an “inflamed” jury and “junk science” for a verdict of $289 million in damages to a man who said the company’s Roundup weed killer caused his cancer, according to some legal experts.
Monsanto said the plaintiff’s experts should have been excluded because although they mainly cited respected, peer-reviewed studies, they inappropriately cherry-picked results and used unreliable methods to support the position that glysophate causes cancer in humans.
But Alexandra Lahav, a law professor at the University of Connecticut, said it was common for experts to rely on the same studies and reach different conclusions to present to a jury during trial.
Exxon Sues the Suers in Fierce Climate-Change Case
Bloomberg Businessweek online
As climate-change lawsuits against the oil industry mount, Exxon Mobil Corp. is taking a bare-knuckle approach rarely seen in legal disputes: It’s going after the lawyers who are suing it.
The company has targeted at least 30 people and organizations, including the attorneys general of New York and Massachusetts, hitting them with suits, threats of suits or demands for sworn depositions.
Hillary Clinton says Bernie Sanders wants higher standards for toy guns than real guns
"A hypothetical situation might be if a city experienced an epidemic of deaths or injuries that resulted from a prevalence of realistic-looking toy guns; think of the recent story of Tamir Rice, a Cleveland child carrying a toy gun who a police officer shot and killed, said Alexandra Lahav, a professor of civil procedure at the University of Connecticut School of Law. In that case, a city might want to bring a suit against the toy gun manufacturer or seller for creating a public nuisance. But under the 2005 law, a city cannot sue a gun company if there is an epidemic of people being injured or killed by their guns."
ACLU family separation case highlights alternate path for Trump challengers
Law professor Alexandra Lahav of the University of Connecticut, a class action procedure expert, told me that civil rights advocates have been relied on sweeping class action injunctions to challenge state and federal policies since before the modern federal rules of procedure for class actions were adopted in 1966. In fact, according to a post Lahav and three other law profs wrote for the Harvard Law Review last month, the class action rules were drafted with these cases in mind, “to address precisely the scenario where a government policy systematically denies a group of plaintiffs a meaningful opportunity to vindicate their rights.”
Due process challenges against government agencies – exactly like the ACLU’s family separation case – have been considered particularly appropriate for sweeping class action treatment, the profs wrote, because “they often raise generic questions about how uniform hearing procedures impact a group of people who depend on them for relief.”
To what extent should procedural law take into account the resources of participants in the legal system? The assumption in the United States is that the legal system does not require symmetry between litigants. Courts take litigants as they find them. There are at least three exceptions to this general rule: the provision of an attorney by the state in certain limited circumstances, fee shifting in the ...
How should due process doctrine constrain the class action device and other forms of aggregate litigation that look and feel like class actions? Since courts' conceptions of due process determine the scope of collective litigation, this short Essay considers these conceptions of due process and asks what ought they be. Its main contribution is to demonstrate how conceptions of due process ...
Are class actions unconstitutional? Many people—defendants and conservative legislators, not to mention scholars at the American Enterprise Institute—would like them to be. For opponents of the class action, Martin Redish's book Wholesale Justice* provides some of the most theoretically sophisticated arguments available. The book is a major contribution both to the scholarly literature on class ...
That like cases ought to be treated alike is a basic common law principle. Judges recognize that consistency in case outcomes is a characteristic of the rule of law. 2 Yet our civil justice system tolerates a great 2. See, eg, Exxon Shipping Co. v. Baker, 128 S. Ct. 2605, 2624-26 (2008)(lamenting unpredictability in punitive damages awards); Martin v. Franklin Capital Corp., 546 US 132, 139 (2005) ...
Class actions present a series of dualities. There are two dominant views of the class action's structure and two dominant views of the class action lawyer. Some see the class action as an aggregation of individuals, a complex joinder device and nothing more. Others view the class action as transforming the class members into an entity. Similarly, there are two dominant views of the class action lawyer ...